[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"qtc-intervals-changes\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:qtc-intervals-changes":26},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,43],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":4,"eligibilityCriteria":14,"healthyVolunteers":11,"sex":15,"minAge":4,"maxAge":16,"enrollmentInfo":17,"targetDuration":4,"studyType":20,"phases":4,"briefSummary":21,"conditions":22,"keywords":27,"overallStatus":30,"whyStopped":4,"lastUpdateSubmitDate":31,"lastUpdatePostDateStruct":32,"startDateStruct":35,"completionDateStruct":37,"leadSponsor":39,"locationsCount":42},"100582952","psychotropic-drug-induced-qt-prolongation-and-ecg-monitoring-in-the-pediatric-population-100582952",false,"NCT06870006","Psychotropic-Drug-induced QT Prolongation and ECG Monitoring in the Pediatric Population","Inclusion Criteria:\n\n* Admitted to psychiatry ward\n* Starting a psychotropic drug acting on QT interval\n\nExclusion Criteria:\n\n* Age \\>18aa\n* History of administration of drug acting on QT interval in the 3 months prior","ALL","18 Years",{"count":18,"type":19},100,"ESTIMATED","OBSERVATIONAL","Electrocardiogram (ECG) Q-T prolongation is a cardiac electrophysiological disorder associated with the occurrence of arrhythmias potentially fatal. Several psychotropic drugs are associated with an increased risk of QT prolongation, which is why in clinical practice a baseline ECG is performed before a psychotropic drug is prescribed. However, there are no validated protocols establishing when to repeat this examination or describing clinical events when this examination should be repeated in clinical follow-up.\n\nThe study aims to investigate the incidence of QTc prolongation events as a side effect of chronic psychotropic drug administration. For this purpose, ECGs will be recorded and confounding factors of patients at the beginning of psychotropic therapy and after 3, 6 and 12 months will be analyzed.",[23,24,25,26],"Eating Disorders","Mood Disorders in Children and Adolescents","Psychotic Disorder","QTc Intervals Changes",[28,29],"QTc interval","psychotropic drugs","RECRUITING","2026-03-17",{"date":33,"type":34},"2026-03-18","ACTUAL",{"date":36,"type":34},"2024-01-01",{"date":38,"type":19},"2027-01",{"name":40,"class":41},"Meyer Children's Hospital IRCCS","OTHER",6,{"id":44,"slug":45,"hasResults":11,"nctId":46,"briefTitle":47,"officialTitle":48,"acronym":4,"eligibilityCriteria":49,"healthyVolunteers":11,"sex":15,"minAge":16,"maxAge":4,"enrollmentInfo":50,"targetDuration":4,"studyType":20,"phases":4,"briefSummary":52,"conditions":53,"keywords":55,"overallStatus":30,"whyStopped":4,"lastUpdateSubmitDate":59,"lastUpdatePostDateStruct":60,"startDateStruct":62,"completionDateStruct":64,"leadSponsor":66,"locationsCount":68},"100571942","droperidol-and-qtc-interval-changes-in-ed-patients-100571942","NCT06726811","Droperidol and QTc Interval Changes in ED Patients","Low-Dose Droperidol and Its Association with QTc Interval Changes in Emergency Department Patients","Inclusion Criteria:\n\n* ED patients ages 18 years or older in a cardiovascular-monitored bed who have both an ECG and a 2.5 mg dose of IV droperidol ordered by their treating physician will be eligible for inclusion.\n\nExclusion Criteria:\n\n* Refusal to provide consent.\n* Administration of droperidol before the first ECG is performed.\n* Inability to complete the consent form and questionnaire due to clinical instability, severe pain, or disorientation as determined by a study physician.",{"count":51,"type":19},500,"Objectives To assess the association of low-dose Droperidol administration in the emergency department with changes in the QTc interval.\n\nHypothesis Our study is designed to test the null hypothesis that there will be no clinically significant change in QTc interval after administration of 2.5mg of IV Droperidol during an emergency department visit.",[54,26],"Emergency Department Patient",[56,57,58],"Droperidol","QTc Interval Changes","Emergency Department Patients","2024-12-12",{"date":61,"type":34},"2024-12-17",{"date":63,"type":34},"2024-10-17",{"date":65,"type":19},"2026-09-30",{"name":67,"class":41},"CHRISTUS Health",1]